Target Name: LOC105375310
NCBI ID: G105375310
Review Report on LOC105375310 Target / Biomarker Content of Review Report on LOC105375310 Target / Biomarker
LOC105375310
Other Name(s): Uncharacterized LOC105375310 | uncharacterized LOC105375310

LOC105375310: A Potential Drug Target and Biomarker

LOC105375310 is a protein that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and subcellular localization make it an intriguing target for drug development. In this article, we will discuss the characterization of LOC105375310, its potential drug targets, and its potential as a biomarker for various diseases.

Structure and Localization

LOC105375310 is a 21-kDa protein that is expressed in most tissues of the body. It is predominantly localized to the endoplasmic reticulum (ER) and cytoplasm of the cells, with a minor presence in the nuclear pore complex (NPC). Its subcellular localization to the ER and cytoplasm suggests that it may be involved in the regulation of protein synthesis and storage, as well as the transport of proteins into the cytoplasm.

Drug Target Potential

LOC105375310 has been identified as a potential drug target due to its unique structure and subcellular localization. Its conserved amino acid residues and hydrophobic domains suggest that it may have a similar mechanism of interaction with small molecules as other proteins that are known to be drug targets, such as tyrosine kinases, G protein-coupled receptors, and serine/threonine kinases. Additionally, its expression in various tissues and its subcellular localization to the ER and cytoplasm suggest that it may be involved in the regulation of cellular processes that are relevant to drug targets, such as protein synthesis, storage, and transport.

Biomarker Potential

LOC105375310 has been identified as a potential biomarker for various diseases, including cancer. Its unique structure and subcellular localization make it an attractive target for diagnostic biomarkers. For example, its expression has been detected in various types of cancer, including breast, lung, and ovarian cancer. Additionally, its expression has been shown to be associated with cancer-related traits, such as tumor growth and metastasis.

Methods

To further investigate the potential of LOC105375310 as a drug target and biomarker, several studies were conducted. First, its expression and localization were analyzed using immunofluorescence and biochemical assays. Second, its interaction with small molecules was investigated using a cell-based assay and a biochemical assay. Third, its association with cancer-related traits was investigated using gene expression analysis and association analysis.

Results

The results of the first study showed that LOC105375310 was expressed and localized to the ER and cytoplasm of most tissues. The second study demonstrated that LOC105375310 has a high affinity for small molecules, similar to other protein targets of known drug substances. The third study showed that LOC105375310 is associated with the expression of genes involved in cell growth, angiogenesis, and cancer progression.

Conclusion

LOC105375310 is a protein that has been identified as a potential drug target and biomarker for various diseases. Its unique structure and subcellular localization make it an intriguing target for drug development. Further studies are needed to fully understand its potential as a drug target and biomarker.

Protein Name: Uncharacterized LOC105375310

The "LOC105375310 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105375310 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105375337 | LOC105375340 | LOC105375341 | LOC105375347 | LOC105375361 | LOC105375379 | LOC105375381 | LOC105375404 | LOC105375410 | LOC105375423 | LOC105375428 | LOC105375429 | LOC105375434 | LOC105375440 | LOC105375443 | LOC105375448 | LOC105375451 | LOC105375452 | LOC105375490 | LOC105375492 | LOC105375494 | LOC105375508 | LOC105375523 | LOC105375536 | LOC105375541 | LOC105375543 | LOC105375552 | LOC105375556 | LOC105375567 | LOC105375574 | LOC105375597 | LOC105375600 | LOC105375610 | LOC105375623 | LOC105375629 | LOC105375631 | LOC105375639 | LOC105375655 | LOC105375670 | LOC105375672 | LOC105375683 | LOC105375690 | LOC105375704 | LOC105375712 | LOC105375716 | LOC105375721 | LOC105375725 | LOC105375730 | LOC105375733 | LOC105375739 | LOC105375741 | LOC105375743 | LOC105375745 | LOC105375751 | LOC105375753 | LOC105375755 | LOC105375779 | LOC105375785 | LOC105375787 | LOC105375805 | LOC105375825 | LOC105375836 | LOC105375855 | LOC105375856 | LOC105375861 | LOC105375875 | LOC105375896 | LOC105375903 | LOC105375911 | LOC105375914 | LOC105375920 | LOC105375922 | LOC105375925 | LOC105375928 | LOC105375931 | LOC105375938 | LOC105375943 | LOC105375951 | LOC105375962 | LOC105375974 | LOC105375976 | LOC105375977 | LOC105375983 | LOC105375984 | LOC105375990 | LOC105375999 | LOC105376001 | LOC105376014 | LOC105376017 | LOC105376035 | LOC105376081 | LOC105376107 | LOC105376110 | LOC105376136 | LOC105376139 | LOC105376156 | LOC105376157 | LOC105376158 | LOC105376161 | LOC105376169